| 发明名称 |
COMBINATION THERAPY FOR NON-SMALL CELL LUNG CANCER POSITIVE FOR EGFR MUTATION |
| 摘要 |
The present invention features methods of treating lung cancer (e.g., NSCLC) with an anti-PD-L1 antibody and a tyrosine kinase inhibitor in a subject identified as having an EGFR mutation-positive tumor. |
| 申请公布号 |
WO2016170157(A1) |
申请公布日期 |
2016.10.27 |
| 申请号 |
WO2016EP59083 |
申请日期 |
2016.04.22 |
| 申请人 |
MEDIMMUNE LIMITED |
发明人 |
DAR, Mohammed, M;KARAKUNNEL, Joyson, J;JIANG, Haiyi;KIRKBY, Maxwell, J |
| 分类号 |
A61K39/395;A61K31/517;A61P35/00 |
主分类号 |
A61K39/395 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
